Medical Simulation Market Size, Share & Trends Analysis Report By Product & Services (Healthcare Simulation Software, Simulation Training Services), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
Surgical Scissors Market Growth & Trends
The global surgical scissors market size is expected to reach USD 552.9 million by 2030, according to a new report by Grand View Research, Inc., registering at a CAGR of 6.7% from 2025 to 2030. The rise in demand for minimally invasive surgical procedures along with the high adoption of stainless steel surgical scissors are factors estimated to secure the market position.
The constant rise in the geriatric population base is aggregating the financial demands on the health care system. According to the Population Reference Bureau, the number of Americans aged 65 and over is expected to nearly double from 52.0 million in 2019 to 95.0 million by 2060. Such a rise in the elderly population will consequently result in greater demand for surgical scissors used for various surgical procedures, hence augmenting the market progression.
The rising number of road accidents is expected to augment the demand for surgical scissors. According to the WHO, more than 10 million people are injured or disabled due to road accidents each year, creating a demand for surgeries. Such wounds are commonly managed using surgical scissors. Hence, an increasing number of road accidents is expected to positively impact the demand for surgical scissors, during the forecast period.
Surgical scissors market players are also facing challenges due to COVID-19. The pandemic is making it difficult for market players to make informed decisions regarding product development, supplies, product approvals, and regulatory obligations. Frequent changes being made by the regulatory authorities and the implementation of several new regulations are among the factors, expected to impact the position of market players.
COVID-19 has also impacted market players financially and has led to a decline in sales or revenue figures. This is because people are avoiding non-COVID-19 surgical procedures, which is negatively impacting market players' emergent product lines.
Surgical Scissors Market Report Highlights
- Based on type, the surgical scissors market is classified into reusable and disposable. The reusable segment held the largest market share, accounting for around 64.5% in 2024, owing to their increasing preference and adoption rates across the globe.
- Based on application, the market is segmented into cardiology, orthopedics, oral & throat, dermatology, neurology, gastroenterology, and others.
- The stainless-steel segment accounted for the largest revenue share of 26.8% in 2024. This is primarily due to stainless steel's exceptional durability, corrosion resistance, and ease of sterilization, making it the preferred material for surgical instruments.
- The hospitals & clinics segment accounted for the largest revenue share of 53.3% in 2024. The number of surgeries performed in hospitals is higher than that in any other health setting, owing to the favorable reimbursement structure and availability of hospitals for primary care in several developing countries.
- Chapter 1 Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Segment Definition
- 1.1.1.1 Product & Services Segment
- 1.1.1.2 Technology Segment
- 1.1.1.3 End Use Segment
- 1.2 Regional Scope
- 1.2.1 Estimates and Forecast Timeline
- 1.3 Objectives
- 1.3.1 Objective – 1
- 1.3.2 Objective – 2
- 1.3.3 Objective – 3
- 1.4 Research Methodology
- 1.5 Information Procurement
- 1.5.1 Purchased Database
- 1.5.2 GVR’s Internal Database
- 1.5.3 Secondary Sources
- 1.5.4 Primary Research
- 1.5.5 Details of Primary Research
- 1.6 Information or Data Analysis
- 1.6.1 Data Analysis Models
- 1.7 Market Formulation & Validation
- 1.8 Model Details
- 1.8.1 Consensus-Based Estimates & Forecasting
- 1.8.1.1 Commodity Flow Analysis (Model 1)
- 1.8.1.1.1 Segment-Level Company Revenue Estimates: A Key Example
- 1.8.1.2 Parent market Analysis
- 1.8.1.3 Secondary reliable published data
- 1.8.1.4 Top-Down market estimation
- 1.8.1.5 Country-based segment share calculation
- 1.8.1.6 Medical Simulation Market: CAGR Calculation
- 1.9 List of Secondary Sources
- 1.10 List of Abbreviations
- Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Outlook
- 2.3 Competitive Scenario
- Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Dynamics
- 3.1.1 Market Driver Analysis
- 3.1.1.1 Growing emphasis on patient safety and outcomes
- 3.1.1.2 Shortage of qualified healthcare professionals
- 3.1.1.3 Rising use of simulation, with a growing demand for innovative and custom training approaches to prevent medical errors
- 3.1.1.4 Limited access to patients for educational and clinical development purposes
- 3.1.2 Market Restraint Analysis
- 3.1.2.1 High cost of simulators and limited investment in simulation systems
- 3.1.2.2 Inadequately designed medical simulation equipment
- 3.2 Business Environment Analysis Tools
- 3.2.1 Porter’s Five Forces Analysis
- 3.2.2 PESTL Analysis
- 3.3 Technology Overview
- 3.3.1 Virtual Reality (VR) and Augmented Reality (AR)
- 3.3.2 Artificial Intelligence (AI)
- 3.3.3 Gamification
- 3.3.4 Use of Multidisciplinary Approach in the Development of Simulators
- 3.3.5 3D Printing
- 3.3.6 HCIT/EMR-EHR
- 3.4 Impact of COVID-19 Pandemic
- 3.5 Estimated Number of End Users Per Product Type, at Regional Level
- Chapter 4 Medical Simulation Market: Product & Services Estimates & Trend Analysis
- 4.1 Medical Simulation Product & Services Market: Segment Dashboard
- 4.2 Product Movement & Market Share Analysis, 2024 & 2030
- 4.3 Global Medical Simulation Market, Market Estimates & Forecast, by Product & Services
- 4.3.1 Healthcare Anatomical Models
- 4.3.1.1 Healthcare anatomical models market, 2018 - 2030 (USD Million)
- 4.3.1.2 Type 1
- 4.3.1.2.1 Patient Simulators
- 4.3.1.2.1.1 Patient simulators market, 2018 - 2030 (USD Million)
- 4.3.1.2.1.2 Adult
- 4.3.1.2.1.2.1 Adult market, 2018 - 2030 (USD Million)
- 4.3.1.2.1.3 Pediatrics and Baby Care
- 4.3.1.2.1.3.1 Pediatrics and baby care market, 2018 - 2030 (USD Million)
- 4.3.1.2.2 Task Trainers
- 4.3.1.2.2.1Task trainers market, 2018 - 2030 (USD Million)
- 4.3.1.3 By Fidelity Type
- 4.3.1.3.1 Low-fidelity
- 4.3.1.3.1.1 Low-fidelity market, 2018 - 2030 (USD Million)
- 4.3.1.3.2 Medium-fidelity
- 4.3.1.3.2.1 Medium-fidelity simulators market, 2018 - 2030 (USD Million)
- 4.3.1.3.3 High-fidelity
- 4.3.1.3.3.1 High-fidelity simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4 Type 2
- 4.3.1.4.1 Interventional/Surgical Simulators
- 4.3.1.4.1.1 Interventional/surgical simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.1.2 Laproscopic Surgical Simulators
- 4.3.1.4.1.2.1 Laproscopic surgical simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.1.3 Gynecology Simulators
- 4.3.1.4.1.3.1 Gynecology simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.1.4 Cardiovascular Simulators
- 4.3.1.4.1.4.1 Cardiovascular simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.1.5 Arthroscopic Surgical Simulators
- 4.3.1.4.1.5.1 Arthroscopic surgical simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.1.6 Spine Surgical Simulators
- 4.3.1.4.1.6.1 Spine surgical simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.1.7 Other Interventional/Surgical Simulators
- 4.3.1.4.1.7.1 Other interventional/surgical simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.2 Endovascular Simulators
- 4.3.1.4.2.1 Endovascular simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.3 Ultrasound Simulators
- 4.3.1.6.3.1 Ultrasound simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.4 Dental Simulators
- 4.3.1.4.4.1 Dental simulators market, 2018 - 2030 (USD Million)
- 4.3.1.4.5 Eye Simulators
- 4.3.1.4.5.1 Eye simulators market, 2018 - 2030 (USD Million)
- 4.3.2 Healthcare Simulation Software (Inclusive of Web-Based Simulators)
- 4.3.2.1 Healthcare simulation software market, 2018 - 2030 (USD Million)
- 4.3.3 Simulation Training Services
- 4.3.3.1 Simulation training services market, 2018 - 2030 (USD Million)
- Chapter 5 Medical Simulation Market: Technology Estimates & Trend Analysis
- 5.1 Medical Simulation Technology Market: Segment Dashboard
- 5.2 Technology Movement & Market Share Analysis, 2024 & 2030
- 5.3 Global Medical Simulation Market, Market Estimates & Forecast, by Technology
- 5.3.1 Virtual Patient Simulation
- 5.3.1.1 Virtual patient simulation market, 2018 - 2030 (USD Million)
- 5.3.2 3D Printing
- 5.3.2.1 3D printing market, 2018 - 2030 (USD Million)
- 5.3.3 Procedure Rehearsal Technology
- 5.3.3.1 Procedure rehearsal technology market, 2018 - 2030 (USD Million)
- Chapter 6 Medical Simulation Market: End Use Estimates & Trend Analysis
- 6.1 Medical Simulation End Use Market: Segment Dashboard
- 6.2 Instrument Movement & Market Share Analysis, 2024 & 2030
- 6.3 Global Medical Simulation Market, Market Estimates & Forecast, by End Use
- 6.3.1 Hospitals
- 6.3.1.1 Hospitals market, 2018 - 2030 (USD Million)
- 6.3.2 Research
- 6.3.2.1 Research market, 2018 - 2030 (USD Million)
- 6.3.2.2 Medical Device Companies
- 6.3.2.2.1 Medical device companies market, 2018 - 2030 (USD Million)
- 6.3.2.3 Others
- 6.3.2.3.1 Others market, 2018 - 2030 (USD Million)
- 6.3.3 Academic Institutes
- 6.3.3.1 Academic institutes market, 2018 - 2030 (USD Million)
- 6.3.4 Military Organizations
- 6.3.4.1 Military organizations, 2018 - 2030 (USD Million)
- Chapter 7 Regional Outlook
- 7.1 Regional Outlook
- 7.2 Medical Simulation Market by Region: Key Marketplace Takeaway
- 7.3 North America
- 7.3.1 North America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
- 7.3.2 U.S.
- 7.3.2.1 Key country dynamics
- 7.3.2.2 U.S. medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.3.2.3 Competitive scenario
- 7.3.2.4 Regulatory scenario
- 7.3.3 Canada
- 7.3.3.1 Key country dynamics
- 7.3.3.2 Canada medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.3.3.3 Competitive scenario
- 7.3.3.4 Regulatory scenario
- 7.3.4 Mexico
- 7.3.4.1 Key country dynamics
- 7.3.4.2 Mexico medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.3.4.3 Competitive scenario
- 7.3.4.4 Regulatory scenario
- 7.4 Europe
- 7.4.1 Europe Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
- 7.4.2 UK
- 7.4.2.1 Key country dynamics
- 7.4.2.2 UK medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2.3 Competitive scenario
- 7.4.2.4 Regulatory scenario
- 7.4.3 Germany
- 7.4.3.1 Key country dynamics
- 7.4.3.2 Germany medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3.3 Competitive scenario
- 7.4.3.4 Regulatory scenario
- 7.4.4 France
- 7.4.4.1 Key country dynamics
- 7.4.4.2 France medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4.3 Competitive scenario
- 7.4.4.4 Regulatory scenario
- 7.4.5 Italy
- 7.4.5.1 Key country dynamics
- 7.4.5.2 Italy medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.5.3 Competitive scenario
- 7.4.5.4 Regulatory scenario
- 7.4.6 Spain
- 7.4.6.1 Key country dynamics
- 7.4.6.2 Spain medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.6.3 Competitive scenario
- 7.4.6.4 Regulatory and reimbursement scenario
- 7.4.7 Denmark
- 7.4.7.1 Key country dynamics
- 7.4.7.2 Denmark medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.7.3 Competitive scenario
- 7.4.7.4 Regulatory and reimbursement scenario
- 7.4.8 Sweden
- 7.4.8.1 Key country dynamics
- 7.4.8.2 Sweden medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.8.3 Competitive scenario
- 7.4.8.4 Regulatory scenario
- 7.4.9 Norway
- 7.4.9.1 Key country dynamics
- 7.4.9.2 Norway medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.9.3 Competitive scenario
- 7.4.9.4 Regulatory and reimbursement scenario
- 7.5 Asia Pacific
- 7.5.1 Asia Pacific Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
- 7.5.2 Japan
- 7.5.2.1 Key country dynamics
- 7.5.2.2 Japan medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.5.2.3 Competitive scenario
- 7.5.2.4 Regulatory scenario
- 7.5.3 China
- 7.5.3.1 Key country dynamics
- 7.5.3.2 China medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.5.3.3 Competitive scenario
- 7.5.3.4 Regulatory scenario
- 7.5.4 India
- 7.5.4.1 Key country dynamics
- 7.5.4.2 India medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.5.4.3 Competitive scenario
- 7.5.4.4 Regulatory scenario
- 7.5.5 Australia
- 7.5.5.1 Key country dynamics
- 7.5.5.2 Australia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.5.5.3 Competitive scenario
- 7.5.5.4 Regulatory scenario
- 7.5.6 South Korea
- 7.5.6.1 Key country dynamics
- 7.5.6.2 South Korea medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.5.6.3 Competitive scenario
- 7.5.6.4 Regulatory scenario
- 7.5.7 Thailand
- 7.5.7.1 Key country dynamics
- 7.5.7.2 Thailand medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.5.7.3 Competitive scenario
- 7.5.7.4 Regulatory scenario
- 7.6 Latin America
- 7.6.1 Latin America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
- 7.6.2 Brazil
- 7.6.2.1 Key country dynamics
- 7.6.2.2 Brazil medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.6.2.3 Competitive scenario
- 7.6.2.4 Regulatory scenario
- 7.6.3 Argentina
- 7.6.3.1 Key country dynamics
- 7.6.3.2 Argentina medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.6.3.3 Competitive scenario
- 7.6.3.4 Regulatory scenario
- 7.7 Middle East & Africa (MEA)
- 7.7.1 MEA Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
- 7.7.2 South Africa
- 7.7.2.1 Key country dynamics
- 7.7.2.2 South Africa medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.7.2.3 Competitive scenario
- 7.7.2.4 Regulatory scenario
- 7.7.3 Saudi Arabia
- 7.7.3.1 Key country dynamics
- 7.7.3.2 Saudi Arabia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.7.3.3 Competitive scenario
- 7.7.3.4 Regulatory scenario
- 7.7.4 UAE
- 7.7.4.1 Key country dynamics
- 7.7.4.2 UAE medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.7.4.3 Competitive scenario
- 7.7.4.4 Regulatory scenario
- 7.7.5 Kuwait
- 7.7.5.1 Key country dynamics
- 7.7.5.2 Kuwait medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
- 7.7.5.3 Competitive scenario
- 7.7.5.4 Regulatory scenario
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. CAE, Inc. (Madison Industries acquired CAE healthcare division in October 2023)
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Laerdal Medical
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. 3D Systems, Inc.
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Simulab Corporation
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Limbs & Things Ltd
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Simulaids
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Kyoto Kagaku Co., Ltd
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Gaumard Scientific
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Mentice
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Surgical Science Sweden AB
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. Intelligent Ultrasound
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Product benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. Operative Experience, Inc.
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Product benchmarking
- 8.4.12.4. Strategic initiatives
- 8.4.13. Cardionics, Inc.
- 8.4.13.1. Company overview
- 8.4.13.2. Financial performance
- 8.4.13.3. Product benchmarking
- 8.4.13.4. Strategic initiatives
- 8.4.14. VirtaMed AG
- 8.4.14.1. Company overview
- 8.4.14.2. Financial performance
- 8.4.14.3. Product benchmarking
- 8.4.14.4. Strategic initiatives
- 8.4.15. SYNBONE AG
- 8.4.15.1. Company overview
- 8.4.15.2. Financial performance
- 8.4.15.3. Product benchmarking
- 8.4.15.4. Strategic initiatives
- 8.4.16. IngMar Medical
- 8.4.16.1. Company overview
- 8.4.16.2. Financial performance
- 8.4.16.3. Product benchmarking
- 8.4.16.4. Strategic initiatives
- 8.4.17. TruCorp
- 8.4.17.1. Company overview
- 8.4.17.2. Financial performance
- 8.4.17.3. Product benchmarking
- 8.4.17.4. Strategic initiatives
- 8.4.18. KaVo Dental
- 8.4.18.1. Company overview
- 8.4.18.2. Financial performance
- 8.4.18.3. Product benchmarking
- 8.4.18.4. Strategic initiatives
- 8.4.19. Simendo
- 8.4.19.1. Company overview
- 8.4.19.2. Financial performance
- 8.4.19.3. Product benchmarking
- 8.4.19.4. Strategic initiatives
- 8.4.20. Haag-Streit
- 8.4.20.1. Company overview
- 8.4.20.2. Financial performance
- 8.4.20.3. Product benchmarking
- 8.4.20.4. Strategic initiatives
- 8.4.21. Symgery
- 8.4.21.1. Company overview
- 8.4.21.2. Financial performance
- 8.4.21.3. Product benchmarking
- 8.4.21.4. Strategic initiatives
- 8.4.22. HRV Simulation
- 8.4.22.1. Company overview
- 8.4.22.2. Financial performance
- 8.4.22.3. Product benchmarking
- 8.4.22.4. Strategic initiatives
- 8.4.23. Synaptive Medical
- 8.4.23.1. Company overview
- 8.4.23.2. Financial performance
- 8.4.23.3. Product benchmarking
- 8.4.23.4. Strategic initiatives
- 8.4.24. Inovus Limited
- 8.4.24.1. Company overview
- 8.4.24.2. Financial performance
- 8.4.24.3. Product benchmarking
- 8.4.24.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook